Yupeng Li
- Molecular Biology top 10%
- Oncology top 10%
- Organic Chemistry top 10%
- Immunology top 10%
- Biomedical Engineering
- Co-authors
- Stephen S. HechtJanardhan BanothuKe DingXiaoyun LuXiaomei RenRamesh GondruBart N. LambrechtKim Deswarte
- Topics
- Peptidase Inhibition and Analysis (6 papers)Immunotherapy and Immune Responses (6 papers)Synthesis and Biological Evaluation (5 papers)
- Cited by
- ImmunologyMolecular BiologyOncology
- Partner nations
- ChinaUnited StatesBelgium
In The Last Decade
Yupeng Li
72 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Molecular Biology 832
- Oncology 330
- Organic Chemistry 320
- Immunology 287
- Biomedical Engineering 181
Countries citing papers authored by Yupeng Li
This map shows the geographic impact of Yupeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yupeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yupeng Li more than expected).
Fields of papers citing papers by Yupeng Li
This network shows the impact of papers produced by Yupeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yupeng Li. The network helps show where Yupeng Li may publish in the future.
Co-authorship network of co-authors of Yupeng Li
This figure shows the co-authorship network connecting the top 25 collaborators of Yupeng Li. A scholar is included among the top collaborators of Yupeng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yupeng Li. Yupeng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 12 | |
| 5 | 8 | |
| 6 | 7 | |
| 7 | 4 | |
| 8 | 1 | |
| 9 | 2 | |
| 10 | 12 | |
| 11 | 15 | |
| 12 | 31 | |
| 13 | 15 | |
| 14 | Carcinogenic components of tobacco and tobacco smoke: A 2022 updatebreakdown → | 133 |
| 15 | 7 | |
| 16 | 17 | |
| 17 | 45 | |
| 18 | 10 | |
| 19 | 2 | |
| 20 | 24 |
About Yupeng Li
Yupeng Li is a scholar working on Cancer Research, Molecular Biology and Hematology, having authored 77 papers that have together received 1.8k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (6 papers), Immunotherapy and Immune Responses (6 papers) and Synthesis and Biological Evaluation (5 papers). The work is most often cited by research in Immunology (287 citations), Molecular Biology (832 citations) and Oncology (330 citations). Yupeng Li has collaborated with scholars based in China, United States and Belgium. Frequent co-authors include Stephen S. Hecht, Janardhan Banothu, Ke Ding, Xiaoyun Lu, Xiaomei Ren, Ramesh Gondru, Bart N. Lambrecht, Kim Deswarte, Bruno G. De Geest and Sunil A. David. Their work appears in journals such as Journal of the American Chemical Society, Advanced Materials and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.